CANSINO BIOLOGICS IN

6185
End-of-day quote. End-of-day quote  - 01/15
234.2HKD +1.83%
Prev.230.0000
Open235.4000
High246.6000
Low231.0000
Volume1 950 178
Latest news
4d ago
01/03
12/31
12/30
Chart CANSINO BIOLOGICS INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBullish
Resistance249271271
Spread/Res.-6,0%-14%-14%
Spread/Supp.25%64%64%
Support187143143
Financials
Sales 2020 94,1 M 14,5 M 14,5 M
Net income 2020 -6,87 M -1,06 M -1,06 M
Net cash 2020 2 901 M 448 M 448 M
P/E ratio 2020 -7 789x
Yield 2020 -
Capitalization 68 339 M 10 547 M 10 546 M
EV / Sales 2020 695x
EV / Sales 2021 17,7x
Nbr of Employees 429
Free-Float 37,1%
Company
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in...

>> Read more
Sector :
Biopharmaceuticals
Calendar :
2021-03-29 Earnings Release
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Mean consensus BUY
Number of Analysts 6
Average target price 171,22 CNY
Last Close Price 195,73 CNY
Spread / Highest target 11,1%
Spread / Average Target -12,5%
Spread / Lowest Target -76,4%